Viewing Study NCT03897868


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-03-03 @ 9:45 AM
Study NCT ID: NCT03897868
Status: COMPLETED
Last Update Posted: 2022-07-14
First Post: 2019-03-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
Sponsor: Hanmi Pharmaceutical Company Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module